tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DE:BRM Stock Latest News

Bristol Myers announces expanded approvals for Opdivo in U.S., EU,
The FlyBristol Myers announces expanded approvals for Opdivo in U.S., EU,
2d ago
BMY
Trump Trade: President issues short-term waiver of Jones Act
PremiumThe Fly
Trump Trade: President issues short-term waiver of Jones Act
4d ago
AZN
BMY
Trump claims TrumpRx website offers lowest prices, review says not so, NYT says
PremiumThe Fly
Trump claims TrumpRx website offers lowest prices, review says not so, NYT says
4d ago
AZN
BMY
Bristol Myers price target raised to $60 from $53 at HSBC
PremiumThe Fly
Bristol Myers price target raised to $60 from $53 at HSBC
6d ago
BMY
District court rules federal limits to vaccines not based on science, NYT says
PremiumThe Fly
District court rules federal limits to vaccines not based on science, NYT says
6d ago
AZN
BMY
Colgate-Palmolive names Bristol-Myers CEO Boerner to board
PremiumThe FlyColgate-Palmolive names Bristol-Myers CEO Boerner to board
10d ago
CL
BMY
Curanex appoints two research experts to board of directors
Premium
The Fly
Curanex appoints two research experts to board of directors
11d ago
BMY
CURX
Balanced Outlook on BMY: Positive Mezigdomide Phase III Data Support CELMoD Platform, but Long-Term Execution Risks Warrant Hold Rating
Premium
Ratings
Balanced Outlook on BMY: Positive Mezigdomide Phase III Data Support CELMoD Platform, but Long-Term Execution Risks Warrant Hold Rating
13d ago
BMY
Bristol Myers reports ‘positive’ Phase 3 results from SUCCESSOR-2 study
PremiumThe Fly
Bristol Myers reports ‘positive’ Phase 3 results from SUCCESSOR-2 study
14d ago
BMY
Controversial Prasad leaving FDA, NYT reports
PremiumThe Fly
Controversial Prasad leaving FDA, NYT reports
14d ago
AZN
BMY
Bristol Myers announces U.S. FDA approved Sotyktu for treatment of PsA
PremiumThe Fly
Bristol Myers announces U.S. FDA approved Sotyktu for treatment of PsA
14d ago
BMY
Bristol Myers price target raised to $70 from $65 at UBS
PremiumThe Fly
Bristol Myers price target raised to $70 from $65 at UBS
16d ago
BMY
Bristol Myers Squibb call volume above normal and directionally bullish
PremiumThe FlyBristol Myers Squibb call volume above normal and directionally bullish
19d ago
BMY
Prothena expects to end year with $255M in cash, equivalents
Premium
The Fly
Prothena expects to end year with $255M in cash, equivalents
23d ago
BMY
NVO
Tango Therapeutics weakness an ‘over reaction,’ says Stifel
Premium
The Fly
Tango Therapeutics weakness an ‘over reaction,’ says Stifel
24d ago
BMY
RVMD
Bristol Myers: Biokin reports ‘positive’ results from Phase 3 study of iza-bren
PremiumThe Fly
Bristol Myers: Biokin reports ‘positive’ results from Phase 3 study of iza-bren
24d ago
BMY
Bristol Myers initiated with a Sector Perform at RBC Capital
PremiumThe Fly
Bristol Myers initiated with a Sector Perform at RBC Capital
26d ago
BMY
Bristol Myers’ Reblozyl shows positive results in alpha-thalassemia study
PremiumThe Fly
Bristol Myers’ Reblozyl shows positive results in alpha-thalassemia study
27d ago
BMY
Bristol Myers price target raised to $75 from $66 at Piper Sandler
PremiumThe Fly
Bristol Myers price target raised to $75 from $66 at Piper Sandler
28d ago
BMY
Bristol Myers initiated with an Overweight at Barclays
PremiumThe FlyBristol Myers initiated with an Overweight at Barclays
1M ago
BMY
FDA to begin requiring on clinical trial
Premium
The Fly
FDA to begin requiring on clinical trial
1M ago
AZN
BMY
FDA to begin requiring one clinical trial in drug approvals
Premium
The Fly
FDA to begin requiring one clinical trial in drug approvals
1M ago
AZN
BMY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >